New appointment at Advanced Cancer Therapeutics
This article was originally published in Scrip
Executive Summary
Dr Gilles Tapolsky has joined Advanced Cancer Therapeutics (US) as chief scientific officer. He has more than 20 years' experience in corporate management, research and pharmaceutical development, having previously served as vice-president of product development at Tapestry Pharmaceuticals.